Form 4 for QNRX Quoin Pharmaceuticals Ltd.
Accepted 2024-06-10 00:00:00 ET · period of report 2024-06-07 · accession 0001104659-24-070017 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-06-10 | 2024-06-07 | QNRX | LANGER DENNIS | Dir | S - Sale | $0.73 | -297 | 53 | -85% | -$216.81 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2024-06-07 | S | D | 297 | $0.73 | 53 | D | — | — | (F1) Reported securities are represented by American Depositary Shares ("ADSs"). Each ADS represents one ordinary share of the Issuer. |